Inactive Instrument

Mapi Pharma Ltd Stock

Equities

End-of-day quote Nasdaq Other stock markets
- ^USD	-

Mapi Pharma : Closes $10 Million Investment Led by Shavit Capital	15-05-27	PU
Mapi Pharma : First Patient Treated in Mapi Pharma’s Phase IIa Clinical Trial of GA Depot for Relapsing Remitting Multiple Sclerosis (RRMS)	14-12-17	PU

Managers	Title	Age	Since
Ehud Marom CEO	Chief Executive Officer	73	07-12-31
Nir Bernstein DFI	Director of Finance/CFO	57	13-10-31
Laura Popper CTO	Chief Tech/Sci/R&D Officer	-	-

Members of the board	Title	Age	Since
Dov Pekelman BRD	Director/Board Member	84	-
Ehud Marom CEO	Chief Executive Officer	73	07-12-31
Itamar Borowitz BRD	Director/Board Member	80	09-04-30

Sector

	1st Jan change	Capi.
VERTEX PHARMACEUTICALS INCORPORATED	-2.20%	103B
REGENERON PHARMACEUTICALS, INC.	+1.76%	95.28B
ARGENX SE	+1.46%	22.15B
BIONTECH SE	-15.72%	21.02B
GENMAB A/S	-8.58%	18.15B
WUXI APPTEC CO., LTD.	-38.74%	16.73B
BEIGENE, LTD.	-12.96%	16.05B
NEUROCRINE BIOSCIENCES, INC.	+5.12%	13.68B
SAREPTA THERAPEUTICS, INC.	+36.21%	12.17B